In experimental AF models, fenofibrate contributes to mitigating metabolic remodeling by regulating the PPAR-/sirtuin route 1/PGC-1, effectively reversing the shortening of the atrial refractory period [48]. This evidence concerns the gene PPARGC1A and atrial fibrillation.